pytotinib
Showing 1 - 1 of 1
NSCLC Trial in Guangzhou (inetetamab, Pytotinib)
Recruiting
- Non-small Cell Lung Cancer
- inetetamab
- Pytotinib
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Aug 16, 2021